| Photothermal therapy of glioblastoma multiforme using multiwalled carbon nanotubes optimized for diffusion in extracellular space BN Eldridge, BW Bernish, CD Fahrenholtz, R Singh ACS biomaterials science & engineering 2 (6), 963-976, 2016 | 76 | 2016 |
| Silver nanoparticles selectively treat triple‐negative breast cancer cells without affecting non‐malignant breast epithelial cells in vitro and in vivo J Swanner, CD Fahrenholtz, I Tenvooren, BW Bernish, JJ Sears, ... FASEB bioAdvances 1 (10), 639, 2019 | 68 | 2019 |
| Vav3 enhances androgen receptor splice variant activity and is critical for castration-resistant prostate cancer growth and survival SO Peacock, CD Fahrenholtz, KL Burnstein Molecular endocrinology 26 (12), 1967-1979, 2012 | 59 | 2012 |
| Heterogeneous responses of ovarian cancer cells to silver nanoparticles as a single agent and in combination with cisplatin CD Fahrenholtz, J Swanner, M Ramirez-Perez, RN Singh Journal of Nanomaterials 2017, 2017 | 53 | 2017 |
| A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancer S Rao, LS Lyons, CD Fahrenholtz, F Wu, A Farooq, W Balkan, ... Oncogene 31 (6), 716-727, 2012 | 52 | 2012 |
| Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer CD Fahrenholtz, FG Rick, MI Garcia, M Zarandi, RZ Cai, NL Block, ... Proceedings of the National Academy of Sciences 111 (3), 1084-1089, 2014 | 48 | 2014 |
| Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer N Zhao, SO Peacock, CH Lo, LM Heidman, MA Rice, CD Fahrenholtz, ... Science translational medicine 11 (498), eaaw4636, 2019 | 43 | 2019 |
| Targeting IGF-IR with ganitumab inhibits tumorigenesis and increases durability of response to androgen-deprivation therapy in VCaP prostate cancer xenografts CD Fahrenholtz, PJ Beltran, KL Burnstein Molecular cancer therapeutics 12 (4), 394-404, 2013 | 42 | 2013 |
| Targeting breast cancer with sugar-coated carbon nanotubes CD Fahrenholtz, M Hadimani, SB King, SV Torti, R Singh Nanomedicine 10 (16), 2481-2497, 2015 | 39 | 2015 |
| Large‐Pore Functionalized Mesoporous Silica Nanoparticles as Drug Delivery Vector for a Highly Cytotoxic Hybrid Platinum–Acridine Anticancer Agent Y Zheng, CD Fahrenholtz, CL Hackett, S Ding, CS Day, R Dhall, GS Marrs, ... Chemistry–A European Journal 23 (14), 3386-3397, 2017 | 29 | 2017 |
| Combined photothermal and ionizing radiation sensitization of triple-negative breast cancer using triangular silver nanoparticles J Sears, J Swanner, CD Fahrenholtz, C Snyder, M Rohde, ... International Journal of Nanomedicine, 851-865, 2021 | 23 | 2021 |
| Design and cellular studies of a carbon nanotube-based delivery system for a hybrid platinum-acridine anticancer agent CD Fahrenholtz, S Ding, BW Bernish, ML Wright, Y Zheng, M Yang, X Yao, ... Journal of inorganic biochemistry 165, 170-180, 2016 | 22 | 2016 |
| Evaluation of multiwalled carbon nanotube cytotoxicity in cultures of human brain microvascular endothelial cells grown on plastic or basement membrane BN Eldridge, F Xing, CD Fahrenholtz, RN Singh Toxicology in Vitro 41, 223-231, 2017 | 21 | 2017 |
| Low doses of silver nanoparticles selectively induce lipid peroxidation and proteotoxic stress in mesenchymal subtypes of triple-negative breast cancer CM Snyder, MM Rohde, CD Fahrenholtz, J Swanner, J Sloop, GL Donati, ... Cancers 13 (16), 4217, 2021 | 10 | 2021 |
| A novel calcium-dependent mechanism of acquired resistance to IGF-1 receptor inhibition in prostate cancer cells CD Fahrenholtz, AM Greene, PJ Beltran, KL Burnstein Oncotarget 5 (19), 9007, 2014 | 10 | 2014 |
| Generation of cultured oligodendrocyte progenitor cells from rat neonatal brains EC Larsen, Y Kondo, CD Fahrenholtz, ID Duncan Current Protocols in Stem Cell Biology 6 (1), 2D. 1.1-2D. 1.13, 2008 | 7 | 2008 |
| ACS Biomaterials Science & Engineering BN Eldridge, BW Bernish, CD Fahrenholtz, R Singh American Chemical Society, 2016 | 5 | 2016 |
| Abstract B05: Self-assembling platinum-acridine loaded carbon nanotubes for triple-negative breast cancer chemotherapy CD Fahrenholtz, S Ding, BW Bernish, M Wright, U Bierbach, RN Singh Molecular Cancer Research 14 (2_Supplement), B05-B05, 2016 | 3 | 2016 |
| Abstract B04: systemic delivery of silver nanoparticles and targeting of the folate receptor alpha for the treatment of triple-negative breast cancer JL Swanner, CD Fahrenholtz, RN Singh Molecular Cancer Research 14 (2_Supplement), B04-B04, 2016 | 2 | 2016 |
| Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors in a Neurofibromin-Dependent Manner G Alewine, J Knight, A Ghantae, C Mamrega, B Attiah, RA Coover, ... Journal of Personalized Medicine 12 (7), 1080, 2022 | 1 | 2022 |
Ravi SinghAssociate Professor, Wake Forest School of MedicineVerified email at wakehealth.edu
